AASTOCKS Financial News

HSI¹	25,818.93	+44.79	92.52B
HSCEI¹	8,915.12	+1.29	34.27B

Back Zoom + Zoom - Block Traded

GRAND PHARMA Secures Exclusive Commercialization Rights for Allergy Medicine Neffy in CN
2025-12-23 17:10:01
GRAND PHARMA (00512.HK) entered into a product cooperation agreement with Pediatrix Therapeutics, as announced by GRAND PHARMA.

The Group will acquire the exclusive commercialization rights in Mainland China through cooperative channels and the non-exclusive commercialization rights in Hong Kong Special Administrative Region for the adrenaline nasal spray, Neffy. The Group also plans to achieve localized production within 24 months after the product is approved.
~

AASTOCKS Financial News
Website: www.aastocks.com

(1) HK Indices are real time

Home|RT Quote|Market|News|Indices
Feedback

View: Mobile|Desktop
Lang: 繁|简|EN

Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.